Metraipolis › archive › dc_a783dd1b4ebe

Toxicological insights and safety considerations of vorasidenib in grade 2 astrocytoma and oligodendroglioma — Europe PMC PMID:40171567

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40171567
DOI
10.1097/js9.0000000000002356
License (as archived)
solo-consultazione
Archived
2026-10-06T08:19:25.671Z
SHA-256 of the archived text
c2196b965da52601b2266c31dd7a9fe4763262e8fe263988aaaf3c05d35c9b51
Stable URL of this page
https://metraipolis.com/documento/dc_a783dd1b4ebe

How to cite

Toxicological insights and safety considerations of vorasidenib in grade 2 astrocytoma and oligodendroglioma — Europe PMC PMID:40171567 — Europe PMC (en), https://europepmc.org/article/MED/40171567 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a783dd1b4ebe (Metraipolis archive dc_a783dd1b4ebe, sha256 c2196b965da52601b2266c31dd7a9fe4763262e8fe263988aaaf3c05d35c9b51)
BibTeX
@misc{dca783dd1b4ebe,
  title = {Toxicological insights and safety considerations of vorasidenib in grade 2 astrocytoma and oligodendroglioma — Europe PMC PMID:40171567},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40171567},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a783dd1b4ebe; sha256 c2196b965da52601b2266c31dd7a9fe4763262e8fe263988aaaf3c05d35c9b51},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40171567. Agents can read the archived copy with the MCP tool read_document.